About: Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2000 (uk) article scientifique publié en 2000 (fr) im September 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2000 (ast) scientific article published on 01 September 2000 (en)
publication date	wds:Q73032381-B7F6A7AB-AD03-4557-89E1-FF635F7A2010
publication date	2000-09-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73032381-02D8A656-7745-439B-8538-9F3B84624CB9 wds:Q73032381-17E97F53-6446-416E-A429-4EB741D51168 wds:Q73032381-3AB130CB-3081-4928-9B20-B5748673D765 wds:Q73032381-42BC1E2F-BB7F-4786-AF15-23C263142B4B wds:Q73032381-46BEFE50-E459-42F5-AD4B-FA335E4999D0 wds:Q73032381-52A8642B-015A-41EB-9BEE-45934D151766 wds:Q73032381-7D549021-30AC-4928-B380-ABCB0ACAE237 wds:Q73032381-90EE3F89-5A21-4D94-9D04-2A55A994E9DB wds:Q73032381-99D7D41B-D1A4-4373-BA51-48EE7F93EE77 wds:Q73032381-A201F5B0-802A-42CF-AB3C-1EDD16216EFE wds:Q73032381-A76D0271-98E8-41D0-94AC-0EFAE2AED648 wds:Q73032381-D670CEDF-4A79-4AD3-A770-396F31CD8A19 wds:Q73032381-E07DB9BD-030C-4F53-9B98-6F4B18468B4D wds:Q73032381-ED390AEE-A315-48BC-B45B-A5F83753E812 wds:Q73032381-F0C0D492-ED5A-4853-8F04-9059849C95C1 wds:Q73032381-F97DF812-1248-44FF-AD9F-58ABF9A24BF7
cites work	Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet function Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 Cumulative antiplatelet effect of low-dose enteric coated aspirin Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men Comparison of i.m. lysine acetylsalicylate and oxycodone in the treatment of pain after operation Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects [Effects of 2 doses of lysine acetylsalicylate on platelet aggregation, beta-thromboglobulin and platelet factor 4 in aged atherosclerotic patients]
author name string	wds:Q73032381-0B0A8FFA-CBC9-4224-95C6-EBE2A9775D0E wds:Q73032381-1CB98995-34C5-4CCC-90DD-4DAFC22A9D05 wds:Q73032381-407ACD4C-295E-4A96-B63F-3E10A466719F wds:Q73032381-73F76C7D-0E81-4C6C-A8F3-A7AA66C17C40 wds:Q73032381-E6F4A2D4-D52B-4C6F-86F1-C5FCEE5427E5
author name string	R Altman R Heguilen B Mautner E P Gurfinkel A Scazziota
rdfs:label	Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes (en) Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes (nl)
skos:prefLabel	Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes (en) Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes (nl)
name	Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes (en) Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes (nl)
title	wds:Q73032381-EEF3CAEA-EDC6-4FBD-8AFA-9E6EF1C3AD93
title	Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes (en)
page(s)	wds:Q73032381-58EAAA91-E9BD-4FC7-8A58-FC1292817F24
page(s)	697-700
instance of	wds:Q73032381-28BD69F0-762B-41E5-A64E-B9F29978C128
instance of	scholarly article
main subject	wds:Q73032381-012A3D25-EA68-4245-A579-8BB79654F9BC
main subject	aspirin
PubMed ID	wds:Q73032381-7B88BDA7-B436-4282-814F-A3A57A04788C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11016021
PubMed ID	11016021
published in	wds:Q73032381-8871C184-E184-4254-9DDA-BD2C6FB7914B
published in	Clinical Cardiology
issue	wds:Q73032381-61375915-0B94-40AE-BCA7-6F22AA3AB636
volume	wds:Q73032381-3AFF1CDD-B49B-4C60-8F98-7EF1C0C72F85
issue	9
volume	23
DOI	wds:Q73032381-78860582-E4EB-4C77-A7E3-6402828085AA
DOI	http://dx.doi.org/10.1002/CLC.4960230912
DOI	10.1002/CLC.4960230912
PMCID	wds:Q73032381-0DDCCEC4-EDC2-4C46-8043-B75981E120CF
PMCID	6654778
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73032381
is cites work of	A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial The antithrombotic profile of aspirin. Aspirin resistance, or simply failure? Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome
is cites work of	wds:Q64272828-C25EDCE7-2398-40CA-9CB8-5B9EC17709E2 wds:Q33914835-392EEEC3-FB18-4CAE-A86D-46FB72D36870 wds:Q24794673-9C4875E6-5C34-4FBB-8636-562798D867FD

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software